Nik-Akhtar B, Khorsandi H, Nejatbakhsh A
J Trop Med Hyg. 1977 Jul;80(7):147-8.
Incidences of renal amyloidosis were studied in patients who were in various stages of pulmonary tuberculosis and a three year follow-up gave some opportunity to study the effectiveness of anti-tuberculosis treatment on the course of renal amyloidosis. It was concluded that 9 to 11 per cent of all patients with pulmonary tuberculosis will eventually develop proteinuria due to renal amyloidosis after a certain period of time. It has been postulated that once amyloidosis has extensively involved the kidneys, anti-tuberculous treatment will not cause any regression in the course of renal amyloidosis.
对处于肺结核不同阶段的患者的肾淀粉样变性发病率进行了研究，为期三年的随访为研究抗结核治疗对肾淀粉样变性病程的有效性提供了一些机会。得出的结论是，所有肺结核患者中有9%至11%最终会在一段时间后因肾淀粉样变性而出现蛋白尿。据推测，一旦淀粉样变性广泛累及肾脏，抗结核治疗将不会使肾淀粉样变性病程出现任何逆转。
